abstract |
The invention relates to a method for treating rheumatoid arthritis in a mammal, comprising administering an agent that inhibits the activity of the prostaglandin EP4 receptor (EP4). It also relates to a method for identifying agents that selectively inhibit the activity of EP4 in vi |